“Scientists believe that within five to 10 years, ‘in silico’ trials – in which hundreds of virtual organs are used to assess the safety and efficacy of drugs – could become routine, while patient-specific organ models could be used to personalise treatment and avoid medical complications.”

From The Guardian.